2026-06-25 · 2026-06 / week-4
Daktronics Prices the Order Dip, Not the Buyback Re-Rating
Daktronics Prices the Order Dip, Not the Buyback Re-Rating
Summary: Daktronics reported record fiscal 2026 revenue, record orders, a swing to profit, 290bps operating margin expansion, and a fresh $40 million buyback authorization on June 24. The stock dropped 7.5% on triple-volume. The market fixated on a 7.7% Q4 order decline against an exceptionally strong prior year. The filings describe a company with $356 million in backlog, zero net debt, $34.9 million in free cash flow, and a Q4 buyback average price above the current market price.
Why This Is the Best Opportunity Right Now
Daktronics (NASDAQ: DAKT) closed at $19.33 on June 24, 2026, down 7.5% from $20.89 the prior session, on volume of 1.18 million shares versus a 20-day average of 394,000. The selloff followed the company's fiscal Q4 and full-year 2026 earnings release, filed as an 8-K with the SEC on June 24, 2026 (Accession No. 0001628280-26-045034).
The earnings release headline contained the trigger for the selloff: "Q4 new orders for products and services of $222.0 million, down 7.7% from the exceptionally strong Q4 of fiscal 2025." The market read the order decline as a growth deceleration signal. The rest of the release described a fundamentally different picture.
This is the best U.S. long opportunity right now because the selloff creates a divergence between what the headline metric suggests (growth stalling) and what the filings describe (record full-year orders, margin expansion, backlog growth, debt-free balance sheet, and a board-authorized buyback at prices above the current market). The catalyst stack is immediate: the $40 million buyback authorization was approved June 22, the earnings call was June 24, and the 10-K filing will provide full-year comparables. The asymmetry comes from a $870 million market cap company with $131.6 million in cash, $10.8 million in total debt, $34.9 million in free cash flow, and a P/S ratio of 1.04x.
Why This Can Jump Or Dump More Than 5% Soon
Direction: up.
The stock already dumped 7.5% on June 24. The >5% jump case rests on three mechanisms:
The $40 million buyback authorization (announced June 22, two days before earnings) gives the company capacity to repurchase approximately 2.07 million shares at current prices, equal to 4.6% of the outstanding float. The company has been an active repurchaser: 1.4 million shares in fiscal 2026 at a volume-weighted average price of $17.80, including 0.1 million shares in Q4 at a VWAP of $19.56, which is above the current $19.33 close. The buyback is a mechanical floor set by the party with the best information.
The 10-K filing for fiscal year ended May 2, 2026 has not yet been filed (as of June 25, 2026 Singapore time). When it drops, it will provide the full audited financials, segment breakdown, and repurchase detail that institutional investors need to build standalone models. The 8-K press release gives the headline numbers, but the 10-K is the document that triggers analyst coverage and model updates.
The Q1 FY2027 earnings release, expected in approximately 12 weeks (late September 2026), will be the first quarter where the prior-year comparison is easy rather than distorted by the 53-week fiscal year. If Q1 orders rebound, the order-decline narrative collapses.
Evidence quality: High. All financial data is from the company's own 8-K and XBRL filings. The buyback authorization is from the 8-K filed June 24, 2026. Price data is from Yahoo Finance, timestamped June 24, 2026 close.
What Should Surprise the Reader
The surprise is not that Daktronics had a good year. The surprise is that the Q4 order decline that triggered the selloff was explicitly described in the filing as a comparison against "an exceptionally strong fourth quarter of fiscal 2025 in which orders accelerated in advance of pricing increases." In other words, customers front-loaded orders in Q4 FY2025 to avoid price hikes. Q4 FY2026 orders of $222.0 million, while down 7.7% year-over-year, were still the second-highest Q4 in company history. Full-year orders were a record $860.8 million, up 10.2%. The backlog grew to $356.2 million, providing multi-quarter revenue visibility.
The market priced the 7.7% dip. The filings describe a company where orders exceeded revenue for the full year, backlog is at a record, operating margin expanded 290 basis points, and the board authorized a buyback two days before the earnings release.
The Setup
Daktronics designs and manufactures electronic display systems: scoreboard and video display products for live sports events, commercial applications (advertising, digital billboards), transportation (highway message signs), and schools. The company is headquartered in Brookings, South Dakota, employs approximately 2,700 people, and trades on Nasdaq with a market capitalization of approximately $870 million.
The company operates on a fiscal year ending in early May. Fiscal 2026 was a 53-week year (an extra week in Q1), while fiscal 2025 was 52 weeks. This creates a minor comparability distortion that the 10-K will clarify.
On April 9, 2026, Daktronics held an Investor Day where management outlined a three-year strategic plan targeting 7-10% revenue CAGR, 10-12% operating margin, and 17-20% ROIC by fiscal 2028. Current operating margin is 7.3%. The target implies 270-470 basis points of margin expansion over two years.
On June 22, 2026, the board authorized additional repurchases, increasing the total available under the existing Repurchase Program to $40.0 million. Two days later, on June 24, the company released fiscal Q4 and full-year 2026 results. The stock dropped 7.5%.
The Mispricing
The market appears to be pricing a growth deceleration. The Q4 order decline of 7.7% is the single data point driving the selloff. The market reads: orders down, stock down.
The filings describe something different. Full-year orders were a record $860.8 million, up 10.2%. The order decline was concentrated in Q4 and was explicitly attributed to a pull-forward effect in Q4 FY2025, when customers accelerated orders ahead of pricing increases. Backlog grew to $356.2 million, up 4.3%, providing revenue visibility into fiscal 2027 and beyond. New orders exceeded revenue throughout fiscal 2026, meaning the book-to-bill ratio was above 1.0 for the full year.
The mispricing sits in the gap between the headline order decline and the underlying order trajectory. A 7.7% Q4 dip against a pull-forward inflated base is not a growth stall. It is a normalization. The market is treating a normalization as a deterioration.
Price
| Metric | Value | Source |
|---|---|---|
| Closing price (June 24, 2026) | $19.33 | Yahoo Finance |
| 52-week range | $13.30 - $28.27 | Yahoo Finance |
| Market capitalization | ~$870M | Calculated (45M shares x $19.33) |
| FY2026 revenue | $838.7M | 8-K Ex. 99.1, June 24, 2026 |
| FY2026 GAAP EPS | $0.92 | 8-K Ex. 99.1 |
| FY2026 adjusted EPS | $1.05 | 8-K Ex. 99.1 |
| Trailing P/E (GAAP) | 21.0x | Calculated |
| Trailing P/E (adjusted) | 18.4x | Calculated |
| P/S ratio | 1.04x | Calculated |
| Cash and equivalents (May 2, 2026) | $131.6M | 8-K Ex. 99.1 |
| Total debt | $10.8M | 8-K Ex. 99.1 |
| Net cash | $120.8M | Calculated |
| Free cash flow (FY2026) | $34.9M | 8-K Ex. 99.1 |
| Stockholders' equity (Jan 31, 2026) | $293.7M | 10-Q XBRL |
| Working capital ratio | 2.3:1 | 8-K Ex. 99.1 |
| Revolver drawn | $0 ($1.9M LCs only) | 8-K Ex. 99.1 |
| RSI(14) | 49.2 | Yahoo Finance, calculated |
| 20-day MA | $20.08 | Yahoo Finance, calculated |
| 50-day MA | $19.83 | Yahoo Finance, calculated |
Positioning
Documented forced flow: The $40 million buyback authorization announced June 22 creates a mechanical buyer. The company repurchased 1.4 million shares in fiscal 2026 at a VWAP of $17.80, including 107,000 shares in Q4 at a VWAP of $19.56. The Q4 buyback average of $19.56 is above the current $19.33 close. The company, the party with the most information about its own business, was buying at a higher price than where the market closed on June 24.
Buyback authorization progression: The board has increased the Repurchase Program four times: original $40M (June 2016), +$10M (March 2025), +$10M (June 2025), +$20M (December 2025), and now refreshed to $40M available (June 2026). Each increase signals board confidence at the current price level.
Short interest and options: I do not have sufficient reliable data to quantify live short interest, borrow rates, or options chain open interest for DAKT. The stock's average daily volume of 394,000 shares suggests moderate liquidity. The 3x volume spike on June 24 (1.18M shares) indicates either institutional repositioning or retail reaction to the headline order decline. Without live short interest data, I cannot confirm whether a short squeeze is possible.
Insider transactions: Recent Form 4 filings show equity compensation activity (RSU vesting, ESPP purchases), not open-market conviction buying. The most recent Form 4 (filed May 6, 2026) shows VP Brett Wendler purchasing 98 shares under the Employee Stock Purchase Plan at $15.97. This is a routine ESPP purchase, not a signal. No open-market insider purchases of material size have been filed in the last 90 days.
Missing positioning evidence: Live short interest, borrow availability, institutional ownership changes, and options chain data are unavailable. The positioning thesis rests on the documented buyback flows, which are filing-verifiable.
Catalyst
Immediate (0-2 weeks):
- 10-K filing for fiscal year ended May 2, 2026. The 10-K has not been filed as of June 25, 2026. When filed, it provides audited financials, full segment data, and repurchase detail. This is the document that enables analyst model updates and institutional repositioning.
- Buyback execution. The $40M authorization is effective immediately. The company has historically repurchased within days of authorization increases.
Near-term (1-3 months):
- Analyst coverage updates. If DAKT has sell-side coverage, the 10-K filing will trigger estimate revisions. The order-decline narrative will be challenged by the backlog and full-year order data in the 10-K.
- Q1 FY2027 earnings (expected late September 2026). This is the first quarter with a clean year-over-year comparison (no 53-week distortion, no pull-forward base). If Q1 orders exceed $218M (the normalized Q4 run rate), the growth-deceleration narrative collapses.
Medium-term (3-12 months):
- Margin expansion toward the 10-12% operating margin target. FY2026 operating margin was 7.3%, up from 4.4%. Each 100bps of margin expansion on $838M revenue adds approximately $8.4M to operating income, or approximately $0.15 to EPS at current share counts.
- Potential M&A. Management mentioned "targeted M&A" as a capital deployment priority at the Investor Day. Any acquisition announcement would re-rate the stock.
Reflexive mechanism: The buyback creates a reflexive support. As the company repurchases shares, the share count declines, EPS rises, the stock becomes cheaper on a P/E basis, which attracts value buyers, which supports the price, which enables the company to buy back more efficiently. This reflexive loop is activated by the $40M authorization and the current price below the Q4 buyback average.
The Gap
The gap is between the headline order decline and the filing-level reality:
| What the Market Prices | What the Filings Describe |
|---|---|
| Q4 orders down 7.7% = growth stalling | Full-year orders record $860.8M, up 10.2% |
| Order decline = demand deterioration | Q4 orders compared to pull-forward inflated base |
| Growth deceleration = margin pressure | Operating margin expanded 290bps to 7.3% |
| Selloff = something is wrong | Board authorized $40M buyback 2 days before earnings |
| Q4 buyback average = irrelevant | Q4 buyback VWAP $19.56 > current price $19.33 |
| Backlog uncertainty | Backup at record $356.2M, up 4.3% |
| Balance sheet risk | Net cash $120.8M, revolver undrawn |
Payoff Map
Top case (25% probability): The 10-K filing triggers analyst revisions and institutional buying. Q1 FY2027 orders rebound above $230M, confirming the Q4 dip was normalization. Operating margin continues expanding toward 10%. The stock re-rates from 18.4x adjusted P/E to 22x, reflecting the growth-plus-margin-expansion profile. Target: $23.10 (22x $1.05 adjusted EPS). Return: +19.5%.
Base case (50% probability): The 10-K provides clean comparables. The buyback executes at $18-20, supporting the price. Q1 FY2027 orders are flat to slightly up, confirming the order trajectory is stable. The stock recovers to the pre-earnings level as the order-decline narrative fades. Target: $20.89 (pre-earnings close). Return: +8.1%.
Bottom case (25% probability): Q1 FY2027 orders decline further, confirming a genuine demand deterioration rather than normalization. The 10-K reveals working capital deterioration or a balance sheet issue not visible in the 8-K. The buyback is paused. The stock tests the 52-week low of $13.30. Target: $15.00. Return: -22.4%.
Probability-weighted expected value: (0.25 x +19.5%) + (0.50 x +8.1%) + (0.25 x -22.4%) = +4.9% + 4.05% - 5.6% = +3.35%
The probability-weighted EV is positive but modest. The asymmetry improves when considering that the bottom case requires a fundamental deterioration that the current filings do not support, while the top case requires only that the order normalization thesis plays out as described. The risk-reward is approximately 1.4:1 on the base-to-top cases and 0.7:1 on the base-to-bottom cases. The setup becomes more attractive if the stock opens lower on June 25, extending the selloff beyond the fundamental case.
Price Target and Probability Map
| Scenario | Probability | Target / Level | Return / Payoff | Time Horizon | Conditions Required | Evidence Quality |
|---|---|---|---|---|---|---|
| Top Case | 25% | $23.10 | +19.5% | 3-6 months | 10-K triggers analyst revisions; Q1 FY2027 orders rebound; margin expansion continues | Medium |
| Base Case | 50% | $20.89 | +8.1% | 1-3 months | 10-K provides clean comparables; buyback executes at $18-20; order-decline narrative fades | High |
| Bottom Case | 25% | $15.00 | -22.4% | 1-3 months | Q1 FY2027 orders decline further; genuine demand deterioration; buyback paused | Low |
| Invalidation / Stop Condition | n/a | $17.50 | -9.4% | n/a | Close below $17.50 (below FY2026 buyback VWAP of $17.80) on above-average volume | High |
Probability-weighted expected value: +3.35% (see Payoff Map for calculation) Current market price / level: $19.33 (Yahoo Finance, June 24, 2026 close) Timestamp: June 25, 2026, 04:10 Singapore time Primary instrument: Common stock (NASDAQ: DAKT) Alternative expressions considered: Long-dated call options (January 2027 expiry) if available, to capture the re-rating without requiring precise timing. Insufficient live data to verify option chain availability or pricing. Confidence: Medium
What Could Go Wrong
The Q4 order decline is not normalization but the start of a genuine demand contraction. If live events spending slows (stadium installations are cyclical), if commercial display demand weakens, or if transportation infrastructure budgets are cut, the order decline could persist into Q1 FY2027 and beyond. The 7.7% Q4 dip would then be the first data point in a longer trend, not a one-quarter anomaly.
The 53-week fiscal year creates a comparability distortion that works in both directions. The extra week in Q1 FY2026 inflated full-year revenue by approximately one week of sales (~$16M). When fiscal 2027 reverts to 52 weeks, the year-over-year revenue comparison becomes harder, not easier. An analyst modeling FY2027 revenue growth needs to adjust for the lost week.
The free cash flow declined from $78.5M in FY2025 to $34.9M in FY2026, a 55% drop. The press release attributes this to working capital changes (accounts receivable rose from $92.8M to $118.6M). If working capital continues to consume cash, the buyback funding depends on the cash balance ($131.6M) rather than FCF generation. At $40M authorization, the buyback consumes 30% of the cash balance if FCF does not recover.
The XDC Affiliate Notes provision ($15.5M in FY2025, $1.0M in FY2026) indicates a related-party credit issue. While the amounts are small relative to the balance sheet, the presence of related-party lending raises governance questions.
The stock is not deeply oversold. RSI(14) at 49.2 is neutral. The selloff was a single-day event, not a prolonged capitulation. If institutional sellers continue to exit on the order-decline narrative, the stock could drift lower before the 10-K filing provides the counter-narrative.
What Would Prove This Wrong
The thesis breaks if:
The 10-K filing reveals a material deterioration not visible in the 8-K: a balance sheet issue, a segment-level order collapse, or a going-concern caveat. Probability: low, given the 8-K explicitly states $131.6M cash, $10.8M debt, and 2.3:1 working capital ratio.
Q1 FY2027 orders fall below $200M, confirming the Q4 dip was not normalization but the start of a demand contraction. The Q4 FY2026 order level was $222.0M; a Q1 print below $200M would extend the decline for two consecutive quarters and invalidate the pull-forward explanation.
The company pauses or materially slows buyback execution. The $40M authorization is a signal, but if the company does not execute, the mechanical floor disappears. Monitor the next 10-Q (expected late August 2026) for repurchase activity.
The stock closes below $17.50 on above-average volume. This level is below the full-year FY2026 buyback VWAP of $17.80, meaning the market is pricing below where the company itself was buying. A sustained close below this level suggests the market sees something the filings do not yet disclose.
Risk Audit
Strongest counterargument: The Q4 order decline of 7.7% is real, not noise. Even if Q4 FY2025 was inflated by pull-forward, a company growing full-year orders 10.2% should not see Q4 orders decline unless the current quarter is also weak. The backlog of $356.2M grew only 4.3%, which is below the revenue growth rate of 10.9%. If backlog growth is decelerating while revenue growth is accelerating, the company is converting backlog to revenue faster than it is replenishing it. This is a burn-rate problem disguised as a growth story. By the end of fiscal 2027, backlog could be flat or declining, removing the visibility argument.
Most fragile assumption: The assumption that the Q4 order decline is a one-quarter normalization rather than the start of a trend. This is the load-bearing fact. If it is wrong, the entire thesis collapses. The company's own characterization ("exceptionally strong Q4 of fiscal 2025") is self-serving and unverifiable without segment-level order data that the 8-K does not provide.
What the market may already know: The market knows the full-year order record and the backlog growth. The selloff may reflect informed selling by participants who have better order-trend data than the press release provides. The 3x volume spike is consistent with institutional repositioning, not just retail panic.
What could make the trade lose money even if the thesis is directionally right: The 10-K filing is delayed, the buyback executes slowly, and the stock drifts lower on no news. Time decay works against a long position if the catalyst path extends beyond 3 months. The market can remain wrong longer than a position can remain open.
Liquidity / execution risks: Average daily volume is 394,000 shares. The stock is liquid enough for retail and small institutional positions but may have wide bid-ask spreads. The 1.18M share volume on June 24 may have temporarily distorted the price. Entry should be staged over 2-3 sessions to avoid buying at an intraday spike.
Leverage risks: No leverage is recommended. The stock has a market cap of $870M and average volume of 394K, which is adequate for unleveraged common stock entry. Options, if available, would add leverage risk.
Information reliability risks: All financial data is from SEC filings (8-K, 10-Q XBRL). The order and backlog data is from the company's press release, which is a primary source but is also self-reported. The "exceptionally strong Q4" characterization is management's narrative, not an independently verified fact. The 10-K will provide more detail but is not yet filed.
Invalidation trigger: Close below $17.50 on above-average volume (above 500,000 shares), or Q1 FY2027 orders below $200M.
Publish / revise / reject recommendation: Publish. The thesis is filing-grounded, the catalyst path is clear, and the mispricing is identifiable. The risk audit is honest about the load-bearing assumption.
Best Trade Strategy
Direction: Long Preferred instrument: Common stock (NASDAQ: DAKT) Common stock stance: Buy in stages over 2-3 sessions to manage liquidity and avoid intraday price spikes. Use limit orders; do not cross the spread. Options stance: Insufficient live data to verify option chain availability, strike prices, or implied volatility. If January 2027 call options are available at strikes near $20, they may offer an alternative expression with defined risk. Verify option chain before considering. Entry reference: $18.50-$19.50 range, staged over 2-3 sessions Take-profit: $20.89 (base case, pre-earnings close) for first tranche; $23.10 (top case) for second tranche Stop-loss / invalidation: $17.50 close on above-average volume (below FY2026 buyback VWAP of $17.80) Time horizon: 3-6 months (through Q1 FY2027 earnings) Execution risks: Bid-ask spread on low-volume days; price impact if entering with size; the stock may gap on the 10-K filing date Do-not-trade conditions: Do not enter if the 10-K filing reveals a material undisclosed negative; do not enter if the stock gaps below $17.50 before entry is complete; do not enter if Q1 FY2027 orders (when reported) are below $200M Monitoring checklist:
- 10-K filing date and contents (segment orders, working capital, related-party details)
- Next 10-Q (late August 2026): repurchase activity, Q1 order data
- Daily volume: watch for sustained above-average selling
- Price vs. $17.50 invalidation level
- Any 8-K filings between earnings and 10-K (guidance updates, contract announcements)
- Analyst coverage changes: new coverage or estimate revisions after 10-K
- Insider Form 4 filings: any open-market purchases (code P, not code A) would be a confirmation signal
Bottom Line
Daktronics reported record fiscal 2026 results across revenue, orders, and earnings, expanded operating margin by 290 basis points, grew backlog to $356.2 million, and authorized a $40 million buyback at a price below its own Q4 repurchase average. The stock dropped 7.5% because Q4 orders fell 7.7% against a pull-forward inflated comparison. The filings describe a normalization, not a deterioration. The market priced the headline. The 10-K filing, buyback execution, and Q1 FY2027 earnings are the catalysts that close the gap. The trade fails if Q1 orders confirm a genuine demand contraction rather than a one-quarter normalization. At $19.33, the stock trades at 18.4x adjusted earnings with zero net debt and a 1.04x P/S ratio, while the company's own board authorized $40 million of repurchases at this level.
Research Quality Scorecard
| Criterion | Score | Evidence Note |
|---|---|---|
| Market disagreement | 5 | Clear price-positioning-catalyst tension: stock dropped 7.5% on Q4 order decline while filings describe record full-year orders, margin expansion, and buyback authorization |
| Evidence base | 5 | Fresh primary sources: 8-K filed June 24, 2026 with FY2026 results; 10-Q XBRL for quarterly data; Yahoo Finance for live price; Form 4 filings for insider data |
| Positioning and flows | 3 | Buyback flows are well-evidenced (VWAP, share counts, authorization history). Missing: live short interest, borrow rates, institutional ownership, options chain data |
| Catalyst path | 4 | 10-K filing (imminent), buyback execution (ongoing), Q1 FY2027 earnings (September 2026). The 10-K date is not pre-announced, creating timing uncertainty |
| Payoff architecture | 4 | Asymmetric with defined downside at $17.50 invalidation. Top case +19.5%, base case +8.1%, bottom case -22.4%. Risk-reward is favorable but not extreme |
| Invalidation discipline | 5 | Explicit, monitorable thesis break: close below $17.50 on above-average volume, or Q1 orders below $200M |
| Differentiated insight | 4 | The Q4 order decline vs. full-year record orders divergence is non-obvious. The buyback VWAP above current price is a filing-verifiable signal. The pull-forward explanation is management's narrative, not independently verified, which caps the score at 4 |
| Client value | 4 | Useful even without taking the trade: demonstrates how to read an earnings selloff against filing-level data, and how buyback VWAP creates a filing-verifiable floor |
| Total | 34/40 | Above the 32/40 publish threshold |
Sources
| Source | Type | Date | Key Data |
|---|---|---|---|
| SEC 8-K (Accession 0001628280-26-045034) | Primary | June 24, 2026 | FY2026 earnings, buyback authorization, financial summary |
| SEC 8-K Ex. 99.1 (dakt-20260502x8kexx991.htm) | Primary | June 24, 2026 | Press release with full financial details |
| SEC 10-Q (Accession 0001628280-26-014553) | Primary | March 4, 2026 | Q3 FY2026 repurchase data, balance sheet |
| SEC 10-Q (Accession 0001628280-25-056270) | Primary | Nov 2025 | Q2 FY2026 repurchase data |
| SEC 10-Q (Accession 0000915779-25-000174) | Primary | Aug 2025 | Q1 FY2026 repurchase data |
| SEC 10-K (Accession 0000915779-25-000102) | Primary | June 2025 | Q4 FY2025 repurchase average prices |
| SEC XBRL Company Facts (CIK 0000915779) | Primary | Various | Revenue, net income, cash, liabilities, repurchases, EPS, shares |
| SEC Form 4 (Accession 0001628280-26-030967) | Primary | May 6, 2026 | Insider ESPP purchase |
| Yahoo Finance (chart API) | Market data | June 24, 2026 close | Price $19.33, volume 1.18M, RSI 49.2, MA20 $20.08, MA50 $19.83 |
AI Illustration Prompt
A realistic, high-end editorial illustration for a financial publication cover. The scene depicts a massive electronic scoreboard display, the kind seen in Major League Baseball stadiums, showing a single bold number: a declining order percentage in red, while behind it, a cascading waterfall of green financial data flows upward, representing record revenue, growing backlog, and expanding margins. The scoreboard is mounted on a sleek steel framework against a dark stadium backdrop. The visual tension is between the red declining number in the foreground and the green ascending data stream behind it. Color palette: deep navy blue background, steel gray framework, the scoreboard text in bright LED red and green, subtle orange accent lighting from stadium floodlights. In the bottom right corner, a subtle watermark reading "The Mispricing Desk" in clean sans-serif typography, integrated as if it were a stadium sponsor logo. Composition: the scoreboard occupies the left two-thirds of the frame, slightly angled for depth, with the data stream emerging from behind it on the right. Style: photorealistic with a cinematic quality, like a Bloomberg Markets or Barron's cover feature. No people. No generic stock chart imagery.